BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 4958072)

  • 21. Tubuloreticular structures and antinuclear antibodies in autoimmune and non-autoimmune diseases.
    Helder AW; Feltkamp-Vroom TM
    J Pathol; 1976 May; 119(1):49-56. PubMed ID: 1084417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Biopathology of disseminated lupus erythematosus].
    Youinou P; Amoura Z
    Rev Prat; 1998 Mar; 48(6):603-8. PubMed ID: 9781129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Morphologic and immunomorphologic studies in rheumatoid arthritis and systemic lupus erythematosus].
    Wagner T
    Patol Pol; 1984; 35(1):45-64. PubMed ID: 6333663
    [No Abstract]   [Full Text] [Related]  

  • 24. [DNA as an autoantigen].
    Alarcón Segovia D
    Rev Invest Clin; 2003; 55(2):124-7. PubMed ID: 12827914
    [No Abstract]   [Full Text] [Related]  

  • 25. Critical role of TLR2 and TLR4 in autoantibody production and glomerulonephritis in lpr mutation-induced mouse lupus.
    Lartigue A; Colliou N; Calbo S; François A; Jacquot S; Arnoult C; Tron F; Gilbert D; Musette P
    J Immunol; 2009 Nov; 183(10):6207-16. PubMed ID: 19841185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antiendothelial antibodies in systemic lupus erythematosus in men: the connection with kidney involvement and the antiphospholipid syndrome].
    Nasonov EL; Alekberova ZS; Salozhin KV; Kliukvina NG; Aleksandrova EN; Baranov AA; Le Tonqueze M; Youinou P
    Ter Arkh; 1996; 68(6):46-9. PubMed ID: 8771685
    [No Abstract]   [Full Text] [Related]  

  • 27. FcgammaRIIB deficiency with Fas mutation is sufficient for the development of systemic autoimmune disease.
    Yajima K; Nakamura A; Sugahara A; Takai T
    Eur J Immunol; 2003 Apr; 33(4):1020-9. PubMed ID: 12672068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of antinucleosome antibodies by enzyme-linked immunosorbent assays in patients with systemic lupus erythematosus and other autoimmune systemic diseases.
    Půtová I; Dostal C; Becvar R
    Ann N Y Acad Sci; 2007 Aug; 1109():275-86. PubMed ID: 17785316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Tuberculosis and its treatment and systemic lupus erythematosus (review)].
    Dettlaff Z
    Gruzlica; 1973 Jan; 41(1):61-7. PubMed ID: 4119803
    [No Abstract]   [Full Text] [Related]  

  • 30. [Systemic lupus erythematosus with involvement of the central nervous system].
    Ivanova MM; Blizniuk OI
    Klin Med (Mosk); 1989 Jun; 67(6):15-20. PubMed ID: 2674540
    [No Abstract]   [Full Text] [Related]  

  • 31. Plasma membrane DNA in autoimmune diseases.
    Keyhani J; Servais G; Einollahi N; Keyhani E; Duchâteau J
    Transplant Proc; 1995 Oct; 27(5):2756-8. PubMed ID: 7482903
    [No Abstract]   [Full Text] [Related]  

  • 32. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice.
    Yasuda T; Yoshimoto T; Tsubura A; Matsuzawa A
    Cell Immunol; 2001 Jun; 210(2):77-86. PubMed ID: 11520074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Serodiagnosis of autoimmune diseases].
    Wagner J; Andrassy K
    Dtsch Med Wochenschr; 1992 Oct; 117(41):1573-5. PubMed ID: 1396150
    [No Abstract]   [Full Text] [Related]  

  • 34. [Current viewpoints on the pathogenesis of lupus erythematosus].
    Sönnichsen N; Haustein UF; Barthelmes H
    Z Arztl Fortbild (Jena); 1971 Jun; 65(12):581-5. PubMed ID: 4939579
    [No Abstract]   [Full Text] [Related]  

  • 35. [Specificity of antibodies against native DNA using Crithidia luciliae. Clinical and analytical features of patients with and without antibodies against native DNA in systemic lupus erythematosus].
    Peña Sagredo JL; Riestra Noriega JL; Sánchez Andrada S; Luceño Vázquez A; Rodríguez Valverde V
    Med Clin (Barc); 1984 Jun; 83(3):94-6. PubMed ID: 6384685
    [No Abstract]   [Full Text] [Related]  

  • 36. [Diagnostic significance of the lupus band test].
    Papini M; Calandra P; Thimm GM
    Dermatol Monatsschr; 1990; 176(10):635-6. PubMed ID: 2079127
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunoglobulin G subclass of human antinuclear antibodies.
    Tojo T; Friou GJ; Spiegelberg HL
    Clin Exp Immunol; 1970 Jan; 6(1):145-51. PubMed ID: 4984586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antinuclear antibodies are common in an infectious environment but do not predict systemic lupus erythematosus.
    Cainelli F; Betterle C; Vento S
    Ann Rheum Dis; 2004 Dec; 63(12):1707-8. PubMed ID: 15547107
    [No Abstract]   [Full Text] [Related]  

  • 39. Silica accelerated systemic autoimmune disease in lupus-prone New Zealand mixed mice.
    Brown JM; Archer AJ; Pfau JC; Holian A
    Clin Exp Immunol; 2003 Mar; 131(3):415-21. PubMed ID: 12605693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Membrane autoantibodies in systemic lupus erythematosus: a case of autoimmune hemolytic anemia, antiphospholipid antibodies, and transient acquired activated protein C resistance.
    Staropoli JF; Van Cott EM; Makar RS
    Transfusion; 2008 Nov; 48(11):2435-41. PubMed ID: 18673345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.